… The b-lactamase inhibitors used by either increase was not documented in this … b-lactamase
inhibitors may have a during nosocomial outbreak of multiresistant Klebsiella pneumoniae. …

… Klebsiella pneumoniae is currently one of the most pressing emerging issues in bacterial
resistance. Treatment of K.pneumoniae … new β-lactam/β-lactamase inhibitor combinations, …

… coli and Klebsiella pneumoniae and non-fermenting species such as Pseudomonas
aeruginosa and Acinetobacter baumannii. Key enzyme families include TEM, SHV, CTX-M and …

… Despite β-lactams serving as the cornerstone of our therapeutic armamentarium against
Klebsiella pneumoniae… diverse and clinically relevant β-lactams and β-lactamase inhibitors in K. …

… An aminoglycoside- and ceftazidime-resistant strain of Klebsiella pneumoniae K2 producing
the extendedspectrum ß-lactamase SHV-5 infected or colonized 14 pediatric patients at Guy…

… Imipenem-avibactam and cefepime-avibactam or aztreonam-avibactam and ceftaroline-avibactam
are effective against E coli and K pneumoniae carrying bla OXA-48 , respectively, but …

… Ceftazidime-avibactam is a potential drug for treating Enterobacterales producing
extended-spectrum β-lactamase (ESBL), Klebsiella pneumoniae carbapenemase (KPC), AmpC, and …

… Extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae are often susceptible
in vitro to β-lactam/β-lactamase inhibitor (BLBLI) combination antibiotics, but their use has …

… β-lactamase enzymes to this serious clinical problem. This review highlights recent advances
in β-lactamase inhibitors … catalytically versatile β-lactamases (eg, Klebsiella pneumoniae …

… encoding various ESBLs and AmpC β-lactamase types, by studying the effect of an increased
inoculum, and by evaluating interactions with β-lactamase inhibitors. The contribution of …